03.08.2020 | ASO Author Reflections
ASO Author Reflections: The Theseus Paradox: Marked Lymph Node and Sentinel Lymph Node in pN+ Prechemotherapy Patients: Are They the Same?
verfasst von:
Alejandra García-Novoa, MD, PhD, Benigno Acea-Nebril, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2020
Einloggen, um Zugang zu erhalten
Excerpt
Indication for chemotherapy as initial treatment for early breast cancer has modified its surgical treatment, allowing breast preservation in most patients who develop clinical response.
1 However, in spite of high rates of pathologic complete response (pCR) in the axilla (26–66%), in particular in patients with human epidermal growth factor receptor 2 (HER2)+ and triple-negative tumor subtypes, there is still controversy about deescalation in surgical treatment of the axilla for patients with metastatic lymph nodes at diagnosis (pN+).
2 …